HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
Sub-study 1 (records-based analysis):
- Young women and girls aged 15–24 living with HIV who were pregnant or had recently given birth, and who started HIV prevention services for pregnancy between January 1, 2018, and December 31, 2020.
- Babies born to these young women during that same period.
Sub-study 2 (interviews/discussions):
- Young women and girls aged 15–24 living with HIV who are currently pregnant, were previously pregnant or recently gave birth, or have never been pregnant.
- Healthcare workers at clinics that provide HIV prevention services related to pregnancy.
- Partners, spouses, parents of these young women, and community members involved in the study area.
Sub-study 3 (working together to develop solutions):
- People who took part in Sub-study 2, including young women, healthcare workers, partners, spouses, parents, and community members.
- Members of the research team.
Sub-study 4 (randomised trial):
- Pregnant young women and girls aged 15–24 living with HIV — whether newly diagnosed, previously diagnosed, or transferring from another clinic — who are receiving routine HIV prevention care during pregnancy between January 1, 2026, and June 30, 2026, and can be followed for at least one year until June 30, 2027.
Who may not be able to join:
Sub-studies 1 and 4:
- Young women whose HIV treatment (antiretroviral therapy) status was not recorded in their medical records.
- Young women who had not yet started HIV treatment (Sub-study 1 only).
Sub-studies 2 and 3:
- People who are severely unwell mentally or physically in a way that would prevent them from taking part in study activities.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 0046707302287
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time to ART attrition; Detectable viral load; HIV-free infant survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.